I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Are Patients at Risk for Recurrent Disease Activity After S..:
Laixi Xue
;
K. van Bilsen
;
M. W. J. Schreurs
...
https://www.frontiersin.org/article/10.3389/fmed.2020.00418/full. , 2020
Link:
https://doi.org/10.3389/fmed.2020.00418
RT Journal T1 <Title>Are Patients at Risk for Recurrent Disease Activity After Switching From Remicade® to Remsima®? An Observational Study</Title> UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:e152d3e8b46f4c7a951758b552d87606&Exemplar=1&LAN=DE A1 Laixi Xue A1 K. van Bilsen A1 M. W. J. Schreurs A1 M. E. J. van Velthoven A1 T. O. Missotten A1 A. A. H. J. Thiadens A1 R. W. A. M. Kuijpers A1 P. van Biezen A1 V. A. S. H. Dalm A1 J. A. M. van Laar A1 M. A. W. Hermans A1 W. A. Dik A1 P. L. A. van Daele A1 P. M. van Hagen PB Frontiers Media S.A. YR 2020 K1 infliximab K1 Remicade® K1 Remsima® K1 CTP 13 K1 biosimilar K1 rare or orphan immune-mediated inflammatory diseases (IMIDs) K1 Medicine (General) K1 R5-920 JF https://www.frontiersin.org/article/10.3389/fmed.2020.00418/full LK http://dx.doi.org/https://doi.org/10.3389/fmed.2020.00418 DO https://doi.org/10.3389/fmed.2020.00418 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
